Lymphoproliferative disorder (LPD) is a potentially severe adverse effect of methotrexate (MTX) administration in patients with rheumatoid arthritis (RA). We report a case of MTX-associated LPD (MTX-LPD) in a patient with RA who developed severe pulmonary failure complicated by perforation of the terminal ileum. A 61-year-old woman with RA receiving MTX complained of dyspnea and abdominal pain. She was diagnosed with intestinal perforation and peritonitis, and underwent immediate abdominal surgery. Pathological examinations of the specimen obtained from the resected ileum and a bone marrow aspirate revealed diffuse large B-cell lymphoma. Steroid therapy failed to improve her respiratory failure, but her condition improved after abdominal su...
We present a case of a 67-year-old Japanese man with a serious oropharyngeal ulceration that at firs...
A 91-year-old woman who had been taking methotrexate for approximately 5 years for rheumatoid arthri...
Methotrexate (MTX) is a key anchor drug for rheumatoid arthritis (RA) management. Fibrotic interstit...
Abstract Background Methotrexate-associated lymphoproliferative disorder (MTX-LPD) can present as a ...
A 71-year-old woman being treated with methotrexate (MTX) and tacrolimus (TAC) for rheumatoid arthri...
Methotrexate (MTX), a folic acid antagonist, is widely used in the treatment of neoplasms, psoriasis...
What is known and objective Methotrexate-associated lymphoproliferative disorder (MTX-LPD) is a rare...
Methotrexate is an antimetabolite commonly used in clinical practice for a variety of indications ra...
Rheumatoid arthritis (RA) is the most common systemic, autoimmune, and chronic inflammatory disease ...
Methotrexate has proven to be effective in treating rheumatoid arthritis (RA), and is believed to be...
Methotrexate is an immunomodulator used as first line treatment for patients with rheumatoid arthrit...
Treatment with methotrexate (MTX) in rheumatoid arthritis (RA) can lead to severe side-effects, espe...
Background. Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate (MTX), are associat...
A 58-year-old Japanese woman complained of a painful right maxillary premolar gingiva and ulcer. The...
Methotrexate (MTX) has an antiproliferative, anti-inflammatory, immunomodulatory, and immunosuppress...
We present a case of a 67-year-old Japanese man with a serious oropharyngeal ulceration that at firs...
A 91-year-old woman who had been taking methotrexate for approximately 5 years for rheumatoid arthri...
Methotrexate (MTX) is a key anchor drug for rheumatoid arthritis (RA) management. Fibrotic interstit...
Abstract Background Methotrexate-associated lymphoproliferative disorder (MTX-LPD) can present as a ...
A 71-year-old woman being treated with methotrexate (MTX) and tacrolimus (TAC) for rheumatoid arthri...
Methotrexate (MTX), a folic acid antagonist, is widely used in the treatment of neoplasms, psoriasis...
What is known and objective Methotrexate-associated lymphoproliferative disorder (MTX-LPD) is a rare...
Methotrexate is an antimetabolite commonly used in clinical practice for a variety of indications ra...
Rheumatoid arthritis (RA) is the most common systemic, autoimmune, and chronic inflammatory disease ...
Methotrexate has proven to be effective in treating rheumatoid arthritis (RA), and is believed to be...
Methotrexate is an immunomodulator used as first line treatment for patients with rheumatoid arthrit...
Treatment with methotrexate (MTX) in rheumatoid arthritis (RA) can lead to severe side-effects, espe...
Background. Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate (MTX), are associat...
A 58-year-old Japanese woman complained of a painful right maxillary premolar gingiva and ulcer. The...
Methotrexate (MTX) has an antiproliferative, anti-inflammatory, immunomodulatory, and immunosuppress...
We present a case of a 67-year-old Japanese man with a serious oropharyngeal ulceration that at firs...
A 91-year-old woman who had been taking methotrexate for approximately 5 years for rheumatoid arthri...
Methotrexate (MTX) is a key anchor drug for rheumatoid arthritis (RA) management. Fibrotic interstit...